165 related articles for article (PubMed ID: 33763396)
1. Safety and Feasibility of Antibiotic De-escalation in Critically Ill Children With Sepsis - A Prospective Analytical Study From a Pediatric ICU.
Battula V; Krupanandan RK; Nambi PS; Ramachandran B
Front Pediatr; 2021; 9():640857. PubMed ID: 33763396
[No Abstract] [Full Text] [Related]
2. Antibiotic De-Escalation in Critically Ill Patients with Negative Clinical Cultures.
Roper S; Wingler MJB; Cretella DA
Pharmacy (Basel); 2023 Jun; 11(3):. PubMed ID: 37368430
[TBL] [Abstract][Full Text] [Related]
3. Factors influencing the implementation of antibiotic de-escalation and impact of this strategy in critically ill patients.
Gonzalez L; Cravoisy A; Barraud D; Conrad M; Nace L; Lemarié J; Bollaert PE; Gibot S
Crit Care; 2013 Jul; 17(4):R140. PubMed ID: 23849321
[TBL] [Abstract][Full Text] [Related]
4. De-Escalation of Antibiotics Does Not Increase Mortality in Critically Ill Surgical Patients.
Turza KC; Politano AD; Rosenberger LH; Riccio LM; McLeod M; Sawyer RG
Surg Infect (Larchmt); 2016 Feb; 17(1):48-52. PubMed ID: 26714235
[TBL] [Abstract][Full Text] [Related]
5. Frequency of empiric antibiotic de-escalation in an acute care hospital with an established Antimicrobial Stewardship Program.
Liu P; Ohl C; Johnson J; Williamson J; Beardsley J; Luther V
BMC Infect Dis; 2016 Dec; 16(1):751. PubMed ID: 27955625
[TBL] [Abstract][Full Text] [Related]
6. A retrospective study of antibiotic de-escalation in patients with ventilator-associated pneumonia in Malaysia.
Khan RA; Aziz Z
Int J Clin Pharm; 2017 Aug; 39(4):906-912. PubMed ID: 28643112
[TBL] [Abstract][Full Text] [Related]
7. Collaborative approach of individual participant data of prospective studies of de-escalation in non-immunosuppressed critically ill patients with sepsis.
Gutiérrez-Pizarraya A; Leone M; Garnacho-Montero J; Martin C; Martin-Loeches I
Expert Rev Clin Pharmacol; 2017 Apr; 10(4):457-465. PubMed ID: 28266901
[TBL] [Abstract][Full Text] [Related]
8. Impact of de-escalation of beta-lactam antibiotics on the emergence of antibiotic resistance in ICU patients: a retrospective observational study.
De Bus L; Denys W; Catteeuw J; Gadeyne B; Vermeulen K; Boelens J; Claeys G; De Waele JJ; Decruyenaere J; Depuydt PO
Intensive Care Med; 2016 Jun; 42(6):1029-39. PubMed ID: 27025939
[TBL] [Abstract][Full Text] [Related]
9. Safety and feasibility of antibiotic de-escalation in bacteremic pneumonia.
Khasawneh FA; Karim A; Mahmood T; Ahmed S; Jaffri SF; Mehmood M
Infect Drug Resist; 2014; 7():177-82. PubMed ID: 25061323
[TBL] [Abstract][Full Text] [Related]
10. [Clinical impact of ertapenem de-escalation in critically-ill patients with Enterobacteriaceae infections].
Cuesta DP; Blanco VM; Vallejo ME; Hernández-Gómez C; Maya JJ; Motoa G; Correa A; Matta L; Rosso F; Camargo RD; Muñoz M; Florez E; Nagles J; Ovalle A; Reyes S; Villegas MV
Rev Chilena Infectol; 2019 Feb; 36(1):9-15. PubMed ID: 31095199
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic strategies in severe nosocomial sepsis: why do we not de-escalate more often?
Heenen S; Jacobs F; Vincent JL
Crit Care Med; 2012 May; 40(5):1404-9. PubMed ID: 22430235
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.
de Jong E; van Oers JA; Beishuizen A; Vos P; Vermeijden WJ; Haas LE; Loef BG; Dormans T; van Melsen GC; Kluiters YC; Kemperman H; van den Elsen MJ; Schouten JA; Streefkerk JO; Krabbe HG; Kieft H; Kluge GH; van Dam VC; van Pelt J; Bormans L; Otten MB; Reidinga AC; Endeman H; Twisk JW; van de Garde EMW; de Smet AMGA; Kesecioglu J; Girbes AR; Nijsten MW; de Lange DW
Lancet Infect Dis; 2016 Jul; 16(7):819-827. PubMed ID: 26947523
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic de-escalation in the ICU: how is it best done?
Garnacho-Montero J; Escoresca-Ortega A; Fernández-Delgado E
Curr Opin Infect Dis; 2015 Apr; 28(2):193-8. PubMed ID: 25692272
[TBL] [Abstract][Full Text] [Related]
14. De-escalation of Empiric Antibiotics Following Negative Cultures in Hospitalized Patients With Pneumonia: Rates and Outcomes.
Deshpande A; Richter SS; Haessler S; Lindenauer PK; Yu PC; Zilberberg MD; Imrey PB; Higgins T; Rothberg MB
Clin Infect Dis; 2021 Apr; 72(8):1314-1322. PubMed ID: 32129438
[TBL] [Abstract][Full Text] [Related]
15. Effect of Broad-Spectrum Antibiotic De-escalation on Critically Ill Patient Outcomes: A Retrospective Cohort Study.
Aldardeer N; Qushmaq I; AlShehail B; Ismail N; AlHameed A; Damfu N; Al Musawa M; Nadhreen R; Kalkatawi B; Saber B; Nasser M; Ramdan A; Thabit A; Aldhaeefi M; Al Shukairi A
J Epidemiol Glob Health; 2023 Sep; 13(3):444-452. PubMed ID: 37296351
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of procalcitonin as a biomarker in the management of sepsis: slaying dragons or tilting at windmills?
Sridharan P; Chamberlain RS
Surg Infect (Larchmt); 2013 Dec; 14(6):489-511. PubMed ID: 24274059
[TBL] [Abstract][Full Text] [Related]
17. [Current application of antibiotic de-escalation treatment in children with sepsis and its impact on prognosis].
Zhao Y; Yang N; Liu CF
Zhonghua Er Ke Za Zhi; 2022 Mar; 60(3):203-208. PubMed ID: 35240739
[No Abstract] [Full Text] [Related]
18. Empiric broad-spectrum antibiotic therapy of nosocomial pneumonia in the intensive care unit: a prospective observational study.
Alvarez-Lerma F; Alvarez B; Luque P; Ruiz F; Dominguez-Roldan JM; Quintana E; Sanz-Rodriguez C;
Crit Care; 2006; 10(3):R78. PubMed ID: 16704742
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of an Opt-Out Protocol for Antibiotic De-Escalation in Patients With Suspected Sepsis: A Multicenter, Randomized, Controlled Trial.
Moehring RW; Yarrington ME; Warren BG; Lokhnygina Y; Atkinson E; Bankston A; Collucio J; David MZ; Davis AE; Davis J; Dionne B; Dyer AP; Jones TM; Klompas M; Kubiak DW; Marsalis J; Omorogbe J; Orajaka P; Parish A; Parker T; Pearson JC; Pearson T; Sarubbi C; Shaw C; Spivey J; Wolf R; Wrenn RH; Dodds Ashley ES; Anderson DJ;
Clin Infect Dis; 2023 Feb; 76(3):433-442. PubMed ID: 36167851
[TBL] [Abstract][Full Text] [Related]
20. Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?
Eachempati SR; Hydo LJ; Shou J; Barie PS
J Trauma; 2009 May; 66(5):1343-8. PubMed ID: 19430237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
